Search
China's Original RNA Editing Technology Applied for the First Time Worldwide in the Treatment of Rare Diseases
1 day ago /
Read about 0 minute
Author：小编
On June 10, 2026, the team of Wensheng Wei from Changping Laboratory/Peking University announced that China's original RNA editing technology, LEAPER, has entered clinical research for the first time to treat Duchenne Muscular Dystrophy (DMD). This marks the first international application of RNA editing technology in DMD treatment, with related findings published in Cell.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
